TABLE 1.

Characteristics of patients with CAPD peritonitis caused by beta-hemolytic streptococci reported in the literature

Patient no.	Reference or sourcec	Sex/age (yr)	Underlying diseases other than end stage renal failure	Lancefield grouping (species, if available)	Presence of bacteremia	Other bacteria recovered in peritoneal dialysate	Anibiotic treatmentb	Removal of Tenckhoff catheter	Outcome
1	5	NMa	NM	B	Yes	NM	NM	NM	Died
2	4	F/38	None	A	No	None	i.v. and oral cefalothin, i.v. penicillin G and benzathine penicillin	Yes	Remission
3	6	NM	NM	NM	NM	NM	NM	NM	NM
4	3	F/55	Amyloidosis	A	No	None	i.p. vancomycin	No	Remission
5	LA	NM	NM	A	NM	NM	NM	NM	Remission
6	11	M/1	None	B	Yes	None	i.p. cefazolin and tobramycin, i.v. antibiotics	Yes	Remission
7	11	M/5	None	B	No	None	i.p. cefazolin and tobramycin, i.v. antibiotics	No	Remission
8	2	M/52	None	B (S. agalactiae)	No	None	i.v. vancomycin and i.m and i.p. gentamicin	No	Died
9	LB	M/63	None	B (S. agalactiae)	Yes	None	i.p. vancomycin and gentamicin	No	Remission
10	1	M/70	HIVd infection, diabetes mellitus, acute gastroenteritis caused by Cryptosporidium and Salmonellae	A (S. pyogenes)	No	None	i.p. vancomycin and amikacin	No	Remission
11	LC	M/25	None	B	No	None	i.p. and i.v. piperacillin and cefalothin	No	Remission
12	10	F/23	None	B (S. agalactiae)	No	None	i.p. cefazolin and netilmicin	No	Remission
13	Present report (case 1)	F/38	None	G (S. dysgalactiae)	No	None	i.p. cefazolin and tobramycin, i.p. vancomycin and amikacin, i.v. ceftazidime and amikacin	Yes	Remission
14	Present report (case 2)	M/41	Secondary hyperparathyroidism with total parathyroidectomy and autotransplantation	G (S. dysgalactiae)	No	B. fragilis	i.p. cefazolin and tobranmycin, i.p. vancomycin and amikacin, i.v. penicillin	Yes	Remission

^aNM, not mentioned.

^bi.v., intravenous; i.m., intramuscular; i.p., intraperitoneal.

^cLA, officer et al., letter; LB, Yinnon et al., letter; LC, Pagniez et al., letter.

^dHIV, human immunodeficiency virus.

^eSalmonella enterica serovar Paratyphi B.